Trials / Conditions / Glycogenesis 2 Acid Maltase Deficiency
Glycogenesis 2 Acid Maltase Deficiency
5 registered clinical trials studyying Glycogenesis 2 Acid Maltase Deficiency — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidas NCT01288027 | Genzyme, a Sanofi Company | Phase 4 |
| Terminated | Immune Tolerance Induction Study NCT00701701 | Genzyme, a Sanofi Company | Phase 4 |
| Recruiting | Pompe Pregnancy Sub-Registry NCT00567073 | Genzyme, a Sanofi Company | — |
| Completed | High Dose or High Dose Frequency Study of Alglucosidase Alfa NCT00483379 | Genzyme, a Sanofi Company | Phase 4 |
| Completed | Study About the Evolution of Severe Late Onset Pompe Disease Patient With Pulmonary Dysfunction and Receiving NCT00731081 | Genzyme, a Sanofi Company | — |